Cristhiam M Rojas Hernandez, M.D.

Dr. Rojas Hernandez is a valedictorian graduate of the Medical School at the Universidad del Valle in Cali, Colombia. He completed an internship and residency in Internal Medicine at the Yale University (Bridgeport Hospital program) where he received several awards on professionalism and medical education. Subsequently he trained as a Hematologist and Oncologist at the University of New Mexico Comprehensive Cancer Center. During his fellowship he received recognition as the Laurent T. Visconti Fellow of the Year in 2014.

Having joined MD Anderson in 2014, Rojas Hernandez also serves as the University of Texas/Mc Govern Medical School site director for the clinical rotation in Benign Hematology at MD Anderson Cancer Center.

He has mentored several resident trainees in hematology projects, preparing them to present at national and international conferences and make successful transitions to fellowship careers in hematology. For his work in the education field, he has been named the Faculty Teacher of the year in 2016 by the Hematology and Oncology fellowship program at MD Anderson Cancer Center and received the Smythe Award from the Department of Internal Medicine at the University of Texas/Mc Govern Medical School. Additionally, he received the Faculty Educator of the month of April 2018 at MD Anderson Cancer Center.

Dr. Rojas-Hernandez has research interest in the therapeutic index of the direct oral anticoagulants in cancer population. He participated in the pivotal HOKUSAI CANCER trial (N Engl J Med 2018; 378:615-624) and he has written numerous manuscripts in the topic. He has also interest in the quality of life and treatment adherence to anticoagulation in cancer patients. He is the leader of an international study measuring those parameters in the cancer population (NCT03407469).

Dr. Rojas-Hernandez has developed an international reputation in the field of Cancer Associated Thrombosis; he has participated as speaker in multiple international meetings of the International Society of Thrombosis and Haemostasis, International Conference on Thrombosis and Hemostasis Issues in Cancer, The Multinational Association of Supportive Care in Cancer and the Colombian Association of Palliative Care (ASOCUPAC).